[Drug therapy of cerebral apoplexy].
D000925:Anticoagulants / Q000627:therapeutic use*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002794:Choline / Q000627:therapeutic use; D003580:Cytochromes / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D002504:Meclofenoxate / Q000627:therapeutic use
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D003580:Cytochromes; D005343:Fibrinolytic Agents; D002504:Meclofenoxate; D002794:Choline